Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Journal of Clinical Oncology

Volumn 34, Issue 5, 2016, Pages 460-468

  Hong, Theodore S ^a   Wo, Jennifer Y ^a   Yeap, Beow Y ^a   Ben Josef, Edgar ^c   McDonnell, Erin I ^a   Blaszkowsky, Lawrence S ^a   Kwak, Eunice L ^a   Allen, Jill N ^a   Clark, Jeffrey W ^a   Goyal, Lipika ^a   Murphy, Janet E ^a   Javle, Milind M ^d   Wolfgang, John A ^a   Drapek, Lorraine C ^a   Arellano, Ronald S ^a   Mamon, Harvey J ^b   Mullen, John T ^a   Yoon, Sam S ^a   Tanabe, Kenneth K ^a   Ferrone, Cristina R ^a   Ryan, David P ^a   DeLaney, Thomas F ^a   Crane, Christopher H ^d   Zhu, Andrew X ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ASCITES; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CHILD PUGH SCORE; CLINICAL EVALUATION; CYCLOTRON; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPOFRACTIONATED RADIOTHERAPY; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CANCER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; PROTON THERAPY SYSTEM; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; RADIATION SICKNESS; RASH; STOMACH ULCER; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR THROMBUS; TUMOR VOLUME; VASCULAR TUMOR; VERY ELDERLY; VOMITING; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CLINICAL TRIAL; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DOSE HYPOFRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROTON THERAPY; SURVIVAL RATE;

EID: 84958754046     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.64.2710     Document Type: Article

References (23)

1. Llovet JM, Ricci S, Mazzaferro V, et al; SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390, 2008
2. Valle J, Wasan H, Palmer DH, et al; ABC-02 Trial Investigators: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273-1281, 2010
3. Klein J, Dawson LA: Hepatocellular carcinoma radiation therapy: Review of evidence and future opportunities. Int J RadiatOncol Biol Phys 87:22-32, 2013
4. Bujold A, Massey CA, Kim JJ, et al: Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631-1639, 2013
5. Crane CH, Macdonald KO, Vauthey JN, et al: Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 53:969-974, 2002
6. Tse RV, Hawkins M, Lockwood G, et al: Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657-664, 2008
7. Ohkawa A, Mizumoto M, Ishikawa H, et al: Proton beam therapy for unresectable intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol 30: 957-963, 2015
8. Dawson LA, Ten Haken RK, Lawrence TS: Partial irradiation of the liver. Semin Radiat Oncol 11: 240-246, 2001
9. Wang X, Krishnan S, Zhang X, et al: Proton radiotherapy for liver tumors: Dosimetric advantages over photon plans. Med Dosim 33:259-267, 2008
10. Bush DA, Kayali Z, Grove R, et al: The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial. Cancer 117:3053-3059, 2011
11. Fukumitsu N, Sugahara S, Nakayama H, et al: A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 74:831-836, 2009
12. Yamashita H, Onishi H, Murakami N, et al; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG): Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res (Tokyo) 56:561-567, 2015
13. Goodman KA, Wiegner EA, Maturen KE, et al: Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78:486-493, 2010
14. Takeda A, Sanuki N, Eriguchi T, et al: Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. J Gastroenterol Hepatol 29:372-379, 2014
15. Yoon SM, Lim YS, Park MJ, et al: Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma. PLoS One 8:e79854, 2013
16. Kopek N, Holt MI, Hansen AT, et al: Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94:47-52, 2010
17. Ben-Josef E, Normolle D, Ensminger WD, et al: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23:8739-8747, 2005
18. Andolino DL, Johnson CS, Maluccio M, et al: Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81: e447-e453, 2011
19. Son SH, Jang HS, Jo IY, et al: Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma. Radiat Oncol 9:101, 2014
20. Lee MT, Kim JJ, Dinniwell R, et al: Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27: 1585-1591, 2009
21. Kwon JH, Bae SH, Kim JY, et al: Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 10:475, 2010
22. Son SH, Choi BO, Ryu MR, et al: Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys 78:1073-1080, 2010
23. Chen YX, Zeng ZC, Tang ZY, et al: Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients. BMC Cancer 10: 492, 2010